The overall goal of this research program is to define the signal transduction mechanisms that mediate the response of cells to inflammatory cytokines and environmental stress. A focus of the study is the c-Jun NH2-terminal kinase (JNK) group of MAP kinases, which are activated in response to cytokines and stress. Many of the components of the JNK protein kinase signal transduction pathway have been identified by molecular cloning and have been characterized in biochemical studies. However, an understanding of the functional significance of the JNK signaling pathway in vivo has remained elusive. Recently, the PI has constructed mice with germ-line mutations in the three gene that encode the JNK protein kinases (Jnk1, Jnk2 and Jnk3) and in both of the genes that encode the protein kinases that phosphorylate and activate JNK (Mkk4 and Mkk7). Comparison of cells with wild-type and mutant genotypes can therefore provide important information concerning the physiological function of the JNK signaling pathway. A specific focus of this proposal is to define the functional significance of the JNK signal transduction pathway. Achievement of the goals of this proposal will increase understanding of the MAP kinase signal transduction in vivo. The information represents a basis for the design of novel therapeutic strategies for the treatment of [1] inflammation, and [2] proliferative diseases such as psoriasis and cancer.
The specific aims of this proposal are to examine the effects of the JNK signaling pathway on : 1. Apoptosis and cell survival; 2. Oncogenic transformation and 3. Gene expression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA065861-06
Application #
6093680
Study Section
Medical Biochemistry Study Section (MEDB)
Program Officer
Mccarthy, Susan A
Project Start
1995-07-01
Project End
2005-04-30
Budget Start
2000-05-08
Budget End
2001-04-30
Support Year
6
Fiscal Year
2000
Total Cost
$280,800
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Lu, Huimin; Wang, Tao; Li, Jing et al. (2016) ?v?6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor. Cancer Res 76:5163-74
Han, Myoung Sook; Jung, Dae Young; Morel, Caroline et al. (2013) JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339:218-22
Goel, Hira Lal; Sayeed, Aejaz; Breen, Michael et al. (2013) ?1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1. J Cell Physiol 228:1601-9
Hübner, Anette; Mulholland, David J; Standen, Claire L et al. (2012) JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate. Proc Natl Acad Sci U S A 109:12046-51
Cellurale, Cristina; Girnius, Nomeda; Jiang, Feng et al. (2012) Role of JNK in mammary gland development and breast cancer. Cancer Res 72:472-81
Liu, Wei; Zi, Min; Chi, Hongbo et al. (2011) Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload. J Mol Cell Cardiol 50:702-11
Zou, Weiguo; Greenblatt, Matthew B; Shim, Jae-Hyuck et al. (2011) MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice. J Clin Invest 121:4383-92
Kant, Shashi; Swat, Wojciech; Zhang, Sheng et al. (2011) TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. Genes Dev 25:2069-78
Das, Madhumita; Garlick, David S; Greiner, Dale L et al. (2011) The role of JNK in the development of hepatocellular carcinoma. Genes Dev 25:634-45
Cellurale, Cristina; Sabio, Guadalupe; Kennedy, Norman J et al. (2011) Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation. Mol Cell Biol 31:1565-76

Showing the most recent 10 out of 65 publications